ArticleCurrent oncology (Toronto, Ont.)2022

Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC).

Jason S Agulnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.